Browsing by Author "Li, Bo"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsCopper-mediated oxidative C−H/N−H activations with alkynes by removable hydrazides(2021)
;Xiong, Feng ;Li, Bo ;Yang, Chenrui ;Zou, Liang ;Ma, Wenbo ;Gu, Linghui ;Mei, RuhuaiThe efficient copper-mediated oxidative C–H alkynylation of benzhydrazides was accomplished with terminal alkynes. Thus, a heteroaromatic removable N -2-pyridylhydrazide allowed for domino C–H/N–H functionalization. The approach featured remarkable functional group compatibility and ample substrate scope. Thereby, highly functionalized aromatic and heteroaromatic isoindolin-1-ones were accessed with high efficacy with rate-limiting C–H cleavage. - Some of the metrics are blocked by yourconsent settingsEurus: Towards an Efficient Searchable Symmetric Encryption With Size Pattern Protection(2022)
;Liu, Zheli ;Huang, Yanyu ;Song, Xiangfu ;Li, Bo ;Li, Jin; Dong, Changyu - Some of the metrics are blocked by yourconsent settingsLitter C transformations of invasive Spartina alterniflora affected by litter type and soil source(2020)
;Zhang, Pei; ;Li, Bo ;Lin, Guanghui ;Zhao, JiayuanWu, Jihua - Some of the metrics are blocked by yourconsent settingsVaccination of Macaques with DNA Followed by Adenoviral Vectors Encoding Simian Immunodeficiency Virus (SIV) Gag Alone Delays Infection by Repeated Mucosal Challenge with SIV(2019)
;Almond, Neil ;Berry, Neil ;Stebbings, Richard ;Preston, Mark ;Ham, Claire ;Page, Mark ;Ferguson, Debbie ;Rose, Nicola ;Li, Bo ;Mee, Edward T.Silvestri, GuidoThe simian immunodeficiency virus (SIV) macaque model represents the best animal model for testing new human immunodeficiency virus type 1 (HIV-1) vaccines. Previous studies employing replication-defective adenovirus (rAd) vectors that transiently express SIV internal proteins induced T cell responses that controlled virus load but did not protect against virus challenge. However, we show for the first time that SIV gag delivered in a DNA prime followed by a boost with an rAd vector confers resistance to SIV intrarectal challenge. Other partially successful SIV/HIV-1 protective vaccines induce antibody to the envelope and neutralize the virus or mediate antibody-dependent cytotoxicity. Induction of CD8 T cells which do not prevent initial infection but eradicate infected cells before infection becomes established has also shown some success. In contrast, the vaccine described here mediates resistance by a different mechanism from that described above, which may reflect CD4 T cell activity. This could indicate an alternative approach for HIV-1 vaccine development.